IART Integra LifeSciences: Operating Margin

Corporate emblem and logo of Integra LifeSciences Inc. (IART)

Operating margin dynamics demonstrate the current efficiency of Integra LifeSciences (IART), where 11.60 captures the real-time status of the parameter. Leadership in neurosurgery and patents guarantee the brand strong market positions. In-house implant assembly capacities minimize outsourcing risks. However, the market expects radical measures from new management to rectify past operational failures.

IART: Integra LifeSciences Holdings Corporation Operating Margin 07/04/2022 - 11/19/2026

Integra LifeSciences - analytical breakdowns and key metrics (IART)

- share price and consensus valuation forecast:
Fundamental company analysis:IART, Integra LifeSciences Corp
Brand item of Integra LifeSciences Inc.

Stable operating profitability serves as the foundation for the issuer's long-term investment attractiveness. This metric measures the efficiency of converting revenue into operating profit before financial expenses and taxes. The trend in operating margins demonstrates the business's ability to control costs in real time. For Integra LifeSciences (IART), this indicator will become the primary benchmark for the new management's success. Regaining control over production will directly reflect in the growth of this metric.

Competitors of Integra LifeSciences (IART)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Enovis Corp ENOV|Operating Profitability Establishment Labs Corp (ESTA)|Beta Bionics Inc (BBNX) - Operating Profitability Margin|IRADIMED Inc. - Operating Sales Margin|Operating Margin Embecta Corp. EMBC|Tandem Diabetes Care Inc - Operating Margin|Profitability of Operations AxoGen Inc AXGN|SI-BONE (SIBN) - Operating Profitability|Operating Profit Margin OFIX (Orthofix Corp)|BVS (Bioventus Inc) - Operating Margin|Operating Sales Margin OrthoPediatrics Corp. (KIDS)|Operating Margin TMCI|SRTA - Operating Return on Sales|Operating Profitability Carlsmed Inc CARL|RXST: Return on Sales by Operating Profit|CLPT: Operating Sales Margin|stereotaxis.com - Operating Profit Ratio|NeuroStar (STIM) - Operating Profitability|SGHT - Profitability of Operations|Operating Profitability Orchestra BioMed|Return on Sales by Operating Profit ANIK (Anika Therapeutics)|Operating Profitability inspiremd.com (NSPR)|Jin Medical International Ltd - Return on Sales by Operating Profit|Operating Margin VANI (Vivani Medical Inc)|XTNT: Return on Sales by Operating Profit|NMTC - Operating Profitability|MODD: Operating Profitability|MYO: Operating Margin|envoymedical.com - Operating Profit Rate|Operating Sales Margin VVOS|Operating Return on Sales enVVeno NVNO|Operating Margin SINT|TNON - Operating Return on Sales|Operating Profitability ReWalk Robotics LFWD|AMIX: Return on Sales by Operating Profit|IVF - Operating Profitability|Operating Return on Sales Bone Biologics Corp|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)